Overview: Hepatitis E IgG TestIntroduction: The Hepatitis E IgG Test detects IgG antibodies to hepatitis E to confirm past infection or immunity, preventing liver issues. Aligned with 2023 AASLD guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding vaccination decisions, travel planning, and improving outcomes in serology for patients with suspected hepatitis E exposure, particularly in endemic areas.
Other Names: Anti-HEV IgG Assay, Hepatitis E Immunity Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Hepatitis E antibody testing began in the 1990s after HEV identification. IgG immunoassays improved in the 2000s, enhancing immunity detection.
Purpose: Confirms past hepatitis E infection or immunity, guides vaccination or travel planning, and monitors anti-HEV IgG in patients to prevent liver issues.
Test Parameters: 1. Hepatitis E IgG
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report history of hepatitis E, travel to endemic areas, or symptoms like jaundice.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document history of hepatitis E, travel to endemic areas, or symptoms like jaundice or fatigue. Include current medications and recent infections.
Consent: Written consent required, detailing the tests purpose, immunity implications, and potential need for vaccination or travel precautions.
Procedural Considerations: Uses an immunoassay to detect anti-HEV IgG antibodies. Results are available in 3-5 days, enabling clinical decisions. Performed in laboratories, often for travel-related screening.
Factors Affecting Result Accuracy: Improper sample handling or recent infection can affect results. False negatives may occur in early post-infection testing.
Clinical Significance: Positive anti-HEV IgG indicates immunity from past infection, guiding travel or vaccination decisions. Negative results suggest susceptibility, requiring precautions.
Specialist Consultation: Consult a hepatologist or infectious disease specialist for result interpretation and travel or vaccination planning.
Additional Supporting Tests: Anti-HEV IgM, HEV PCR, or liver function tests to confirm hepatitis E status.
Test Limitations: Early post-infection testing may miss IgG. Clinical correlation is needed for accurate interpretation.
References: AASLD Hepatitis E Guidelines, 2023; Hepatology, Kamar N, 2022.
